Vertex Pharmaceuticals Inc
(NAS:VRTX)
$
493.64
3.64 (0.74%)
Market Cap: 127.13 Bil
Enterprise Value: 121.40 Bil
PE Ratio: 0
PB Ratio: 8.14
GF Score: 93/100 
Vertex Pharmaceuticals Inc at Bank of America Global Healthcare Conference Transcript
May 09, 2023 / 04:20PM GMT
Release Date Price:
$344.83
(+0.22%)
Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst
Welcome to the first morning of the BofA Healthcare Conference. I'm Geoff Meacham. I'm the senior biopharma analyst here, and we're thrilled to have Vertex Pharmaceuticals in the big room, hopefully no protesting this year. But on behalf of Vertex, we have Charlie Wagner, Executive VP and CFO; and David Altshuler, who is CSO and EVP of Global Research. Guys, welcome.
David M. Altshuler
Vertex Pharmaceuticals Incorporated - Executive VP of Global Research & Chief Scientific Officer
Thank you.
Charles F. Wagner
Vertex Pharmaceuticals Incorporated - Executive VP & CFO
Yes, Geoff, thank you. Thanks for hosting.
Geoffrey Christopher Meacham;Charles F. Wagner
BofA Securities, Research Division - Research Analyst;Vertex
So Charlie, you want to disclose the quarter, just give us a little bit of a high level, and then we'll get into some questions.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers